BC
Bicara Therapeutics Inc. Common Stock (BCAX)
NASDAQ·Healthcare·Biotechnology
$9.89
-44.45%
Mkt Cap $1.16B
Analyst Ratings
Buy
5
Hold
4
Sell
0
Price Target (16 analysts)
$32.57
Range $20.00 – $42.00
Implied Upside
+229.2%
Consensus $32.57 vs current $9.89